Germany: Patient21, a healthtech platform, has raised €100m (US$107m) in Series C funding. This significant investment will drive the development of its software platform and fuel its expansion into new European markets. The round was led by Pitango, and joined by Target Global, Piton Capital, PICO Ventures Partners, Bertelsmann Investments, and Artian Investments. “With their…
Home Healthcare Markets International Business Financing round-up: Heartseed, VarmX, InProTher, Patient21